News
The first hybrid BioHackathon Europe
The first ever hybrid BioHackathon Europe was held 8 - 12 November in Barcelona, Spain and welcomed 154 face-to-face and 172 virtual participants. Working collaboratively over tables, screens and time zones on 37 projects, new data, features and friendships were
Posted:
BY-COVID: A new EU project coordinated by ELIXIR
A new EU funded project coordinated by ELIXIR has been launched today. BY-COVID is a €12million Horizon Europe project striving to tackle the data challenges that can hinder effective pandemic response. This interdisciplinary project involves 53 project partners from across
Posted:
ELIXIR funds seven new life science data projects
Seven new Community-led Implementation Studies were launched on 1 June 2021 covering a diverse range of topics across a variety of life science disciplines. Collectively these projects were awarded €1.5 million, funded through ELIXIR’s Core budget, and will run until
Posted:
ELIXIR-CONVERGE releases the RDMkit to make research data management simple
Today, the ELIXIR-CONVERGE project releases one of its main outputs — the RDMkit. Developed and managed by those who work daily with life science data, this research data management kit provides a comprehensive guide with best practices applicable to projects
Posted:
First virtual BioHackathon Europe a success
2020, an unprecedented and surprisingly successful year for BioHackathon Europe Over 300 people attended the 2020 BioHackathon Europe, an intensive week of hacking with experts from all backgrounds; bioinformaticians, software developers and trainers gathered online to improve bioinformatics tools and
Posted:
A beacon in the ocean of SARS-CoV-2 data
An ELIXIR Spain platform allows researchers to browse SARS-CoV-2 variability at the genome, amino acid, structural and motif level. When responding to a health crisis, data play a critical role in identifying drug targets, vaccines or disease-related symptoms, and understanding
Posted:
ELIXIR facilitates development of COVID-19 Disease Map
ELIXIR Nodes contribute to the development of a knowledgebase of SARS-CoV-2 virus host-pathogen interactions. Announced last week in Scientific data, the COVID-19 Disease Map is an international effort to organise the molecular processes underlying the virus-host interactions in COVID-19. Based
Posted:
Sharing experiences for future ELIXIR internships: An interview with Marta Ferri, Beacon Intern at CRG (ELIXIR-ES)
Marta Ferri Peradalta completed her BSc in Biomedical Sciences at the University of Barcelona and followed her passion for Bioinformatics with an MSc at the Pompeu Fabra University in Barcelona. Immediately after her postgraduate studies, she was granted with an
Posted:
Driving Beacon Version 2 development with an invaluable ELIXIR internship
The Centre for Genomic Regulation (ELIXIR-Spain) shares its experience with the intern, Marta Ferri, who helped to propel the Beacon v.2 development this year. The Beacon project was born at the heart of the Global Alliance for Genomics and Health
Posted:
ELIXIR Spain launches tool to study the 3D structure of SARS-CoV-2 proteins
The ELIXIR Node in Spain has created a new COVID-19 tool for 3DBIONOTES-WS Today, the Spanish National Centre for Biotechnology (CNB-CSIC), part of the ELIXIR Spanish Node, launches the 3DBIONOTES-COVID19 tool. The resource is integrated into 3DBIONOTES-WS, a web-based application
Posted:
Hacking the pandemic
Global research community meets online to develop tools for COVID-19 analysis Over 500 scientists, software developers and clinicians joined forces in the COVID-19 virtual Biohackathon to develop new tools for working with the COVID-19 data. The outcomes of the event
Posted:
ELIXIR's Industry events a success
Results from a long-term survey and review of the ELIXIR Innovation and SME Forums - specialised events for life science companies and academics - have revealed an overwhelmingly positive impact of the events, with over 93% of participants stating they
Posted:
European infrastructures lay the foundation for secure access to genomics data
ELIXIR has published a paper in Nature Reviews Genetics today that explores how European research infrastructures can be leveraged to facilitate transnational access to at least one million human genomes. This is building on the recently declared ‘European ‘1+ Million
Posted:
GA4GH and ELIXIR Release V1.0.0 of Beacon API with increased security measures
HINXTON, UK (19 October 2018) — ELIXIR and the Global Alliance for Genomics and Health (GA4GH) have announced the release of the first genomic data interoperability standard from the GA4GH 2018 Strategic Roadmap. The Beacon API v1 is a data
Posted:
ELIXIR part of new IMI project to improve security in drug development
ELIXIR is partner in eTRANSAFE, a new €40 million project funded by the Innovative Medicines Initiative (IMI), which began in September. The five-year project aims to develop an advanced data integration infrastructure and new computational methods to improve security in
Posted:
Supporting public-private partnerships in genomics and health
Over 80 participants from industry and academia gathered in Barcelona on 6-7 June for the ELIXIR Innovation and SME forum. Hosted by ELIXIR Spain, the two-day event showcased successful companies making use of public bioinformatics resources, and presented free bioinformatics
Posted:
ELIXIR Beacons to facilitate sharing of genomics data in Europe
Scientists across the world can now discover and query data from genomics projects in six different countries in Europe. This has been a success of the ELIXIR collaboration with the Global Alliance for Genomics and Health (GA4GH) on the Beacon
Posted:
ELIXIR and GA4GH Beacon Team Up to Advance Genomic Data Sharing
TORONTO, CANADA & HINXTON, UNITED KINGDOM — The Beacon Project of the Global Alliance for Genomics and Health (GA4GH) and ELIXIR, the European infrastructure for life-science data, announced today an expansion of their partnership to develop the Beacon project that
Posted:
Certification for quality of CNAG genomic data
ELIXIR Spain's Centro Nacional de Análisis Genómico (CNAG, National Genome Analysis Centre) has been awarded ISO 17025:2005 certificate for its Next Generation Sequencing Platform. ISO 17025:2005 is an international standard for laboratories that specifies the general requirements for the competence
Posted: